ArticleDiscover oncology2026
Manifold-guided SMOTified dual-channel conditional GAN improving highly-imbalanced biomedical data classification.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Rapidly advancing hardware technology in recent years is significantly accelerating widespread application of deep learning and machine learning algorithms across biomedical and oncological research domains. Although such algorithms have demonstrated superior performance in those domains, their effectiveness in actual biomedical applications is severely constrained by class imbalance issues. To address this problem, this study proposes a novel method termed BSMOTE-DCGAN-EL, which integrates a dual-channel autoencoder conditional generative adversarial network (DCGAN) structure with Borderline Synthetic Minority Oversampling Technique (BSMOTE) generating diverse synthetic minority class samples. Specifically, the proposed DCGAN model leverages manifold features extracting from the original data and their corresponding membership functions (MF), encapsulating rich latent information as conditional features. Furthermore, a bagging-based ensemble learning (EL) algorithm is deployed for mitigating biases toward majority-class samples introduced by traditional classification methods. To validate the effectiveness of the proposed BSMOTE-DCGAN-EL algorithm, experimentation was conducted employing twelve real-world imbalanced biomedical datasets across one widely adopted predictive model. Experimental results demonstrate the proposed method significantly outperforms six state-of-the-art oversampling algorithms and two ablation studies across four evaluation metrics: G-mean, F1, IBA, and AUC. At imbalance ratios of 5, 10, 15, and 20, the proposed approach achieved average improvements of 26.273%, 25.313%, 23.877%, and 21.906%, respectively. Furthermore, statistical analyses employing Friedman and Nemenyi post-hoc tests confirmed the significant superiority of the proposed BSMOTE-DCGAN-EL algorithm over the other six oversampling methods in highly imbalanced data scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.